Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

85 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The CARI guidelines. Endovascular treatment.
MacGinley R, Kumar SK, Mantha M, Mount P, Roberts M, Mangos G; CARI. MacGinley R, et al. Among authors: mount p. Nephrology (Carlton). 2010 Apr;15 Suppl 1:S210-7. doi: 10.1111/j.1440-1797.2009.01243.x. Nephrology (Carlton). 2010. PMID: 20591034 No abstract available.
The CARI guidelines. Role of distal protection devices.
Roberts M, Kumar SK, MacGinley R, Mantha M, Mount P, Mangos G; CARI. Roberts M, et al. Among authors: mount p. Nephrology (Carlton). 2010 Apr;15 Suppl 1:S227-33. doi: 10.1111/j.1440-1797.2009.01245.x. Nephrology (Carlton). 2010. PMID: 20591036 No abstract available.
The CARI guidelines. Inhibition of the renin-angiotensin system.
Mount P, Kumar SK, MacGinley R, Mantha M, Roberts M, Mangos G; CARI. Mount P, et al. Nephrology (Carlton). 2010 Apr;15 Suppl 1:S234-43. doi: 10.1111/j.1440-1797.2009.01246.x. Nephrology (Carlton). 2010. PMID: 20591037 No abstract available.
Baseline characteristics of patients with atypical haemolytic uraemic syndrome (aHUS): The Australian cohort in a global aHUS registry.
Soraru J, Isbel N, Wong G, Coates PT, Mantha M, Abraham A, Juneja R, Hsu D, Brown F, Bose B, Mudge D, Carroll R, Kausman J, Hughes P, Barbour T, Durkan A, Mount P, Lee D, Larkins N, Ranganathan D, Lim WH. Soraru J, et al. Among authors: mount p. Nephrology (Carlton). 2020 Sep;25(9):683-690. doi: 10.1111/nep.13722. Epub 2020 May 31. Nephrology (Carlton). 2020. PMID: 32378251
The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial.
Baigent C, Landray MJ, Reith C, Emberson J, Wheeler DC, Tomson C, Wanner C, Krane V, Cass A, Craig J, Neal B, Jiang L, Hooi LS, Levin A, Agodoa L, Gaziano M, Kasiske B, Walker R, Massy ZA, Feldt-Rasmussen B, Krairittichai U, Ophascharoensuk V, Fellström B, Holdaas H, Tesar V, Wiecek A, Grobbee D, de Zeeuw D, Grönhagen-Riska C, Dasgupta T, Lewis D, Herrington W, Mafham M, Majoni W, Wallendszus K, Grimm R, Pedersen T, Tobert J, Armitage J, Baxter A, Bray C, Chen Y, Chen Z, Hill M, Knott C, Parish S, Simpson D, Sleight P, Young A, Collins R; SHARP Investigators. Baigent C, et al. Lancet. 2011 Jun 25;377(9784):2181-92. doi: 10.1016/S0140-6736(11)60739-3. Epub 2011 Jun 12. Lancet. 2011. PMID: 21663949 Free PMC article. Clinical Trial.
Design and methods of the REMOVAL-HD study: a tRial Evaluating Mid cut-Off Value membrane clearance of Albumin and Light chains in HaemoDialysis patients.
Krishnasamy R, Hawley CM, Jardine MJ, Roberts MA, Cho YJ, Wong MG, Heath A, Nelson CL, Sen S, Mount PF, Pascoe EM, Darssan D, Vergara LA, Paul-Brent PA, Toussaint ND, Johnson DW, Hutchison CA. Krishnasamy R, et al. Among authors: mount pf. BMC Nephrol. 2018 Apr 17;19(1):89. doi: 10.1186/s12882-018-0883-8. BMC Nephrol. 2018. PMID: 29665795 Free PMC article.
85 results